Clinical Trials Browser

Phase 2 × NIH × lintuzumab × Clear all

NCT00006084 2013-12-19

Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute